Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
Go back to Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis| George Foreman Enterprises, Inc. (AMEX: FME) | Delayed: 0.90 -0.05 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.95 | 52 Week High | $0.90 | |||
| Open | $0.90 | 52 Week Low | $0.90 | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $0.00 | |||
| Volume | 20 | |||||
| FRESENIUS MEDICAL CARE AG & CO. KGAA (NYSE: FMS) | Delayed: 22.20 +0.13 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.07 | 52 Week High | $47.52 | |||
| Open | $22.15 | 52 Week Low | $38.61 | |||
| Day High | $22.23 | P/E | N/A | |||
| Day Low | $21.98 | EPS | $0.00 | |||
| Volume | 818,574 | |||||
